Loading...
    Loading...
    LEADERBOARD
labroots
Login here
Register Free
  • LOGIN
  • REGISTER FREE
  • Home
  • Virtual Events
      • Upcoming
      • On-Demand
      • Companies
      • Posters
      • Categories
      See More
      See More
      See More
      See More
      • Health & Medicine
      • Clinical & Molecular DX
      • Immunology
      • Cardiology
      • Cancer
      • Cell & Molecular Biology
      • Genetics & Genomics
      • Microbiology
      • Neuroscience
      • Plants & Animals
      • Earth & The Environment
      • Chemistry & Physics
      • Technology
      • Cannabis Sciences
      • Drug Discovery & Development
  • Webinars
      • Upcoming
      • On-Demand
      • Categories
      See More
      See More
      • Health & Medicine
      • Clinical & Molecular DX
      • Immunology
      • Cardiology
      • Cancer
      • Cell & Molecular Biology
      • Genetics & Genomics
      • Microbiology
      • Neuroscience
      • Plants & Animals
      • Earth & The Environment
      • Chemistry & Physics
      • Technology
      • Cannabis Sciences
      • Drug Discovery & Development
  • Trending News
      • Most Recent
      • What's Hot
      • Categories
      See More
      See More
      • Health & Medicine
      • Clinical & Molecular DX
      • Immunology
      • Cardiology
      • Cancer
      • Cell & Molecular Biology
      • Genetics & Genomics
      • Microbiology
      • Neuroscience
      • Drug Discovery & Development
      • Plants & Animals
      • Cannabis Sciences
      • Earth & The Environment
      • Space & Astronomy
      • Chemistry & Physics
      • Technology
  • Multimedia
      • Sponsored Content
      • eBooks
      • Podcasts
      • Infographics
      See More
      See More
      See More
      See More
  • Products
      • Categories
      • Companies
      • New
      • Popular
      Antibodies
      Immunity, Immunoassay, Immunotherapy
      Assay Kits
      Detection, Quantification
      Biomolecules
      Proteins
      Cell Biology
      Cell function
      Cell-Based Assays
      Cell viability
      Cell/Tissue Culture
      Cell lines, Cell growth, Cell differentiation
      Chemicals and Reagents
      Reagent kits, Laboratory chemicals
      Drug Discovery and Development
      Target identification, High-throughput screening
      Flow Cytometry
      Immunophenotyping, Cell cycle analysis
      Genomics
      Genome sequencing, Transcriptomics
      Imaging (Bio-Imaging / Microscopy)
      Fluorescence imaging
      Lab Automation
      High-throughput screening, Robotics, Liquid handling systems
      Lab Equipment
      Centrifuges, Incubators, Homogenizers, Sonicators
      Life Sciences
      Biological research, Biotechnology
      Molecular Biology
      DNA replication, Gene expression, PCR
      Next Gen Sequencing
      DNA sequencing, High-throughput sequencing, NGS platforms, RNA sequencing, miRNA sequencing, Accessory Products
      Quality Control and Validation
      QC standards, Quality assurance
      Single Cell Analysis
      Transcriptomics
      Technology
      Biotechnology, Instrumentation, Data analysis
      See More
      See More
      See More
  • Companies
      • See More
    • Science Store
        • Men's T-Shirts
        • Women's T-Shirts
        • Accessories
        • Gift Cards
        • Gift Card Balance
        See More
        See More
        See More
        Gift Card $25
        Gift Card $50
        Gift Card $75
        Gift Card $100
        See More
        Labroots Store Gift Card Balance
        $0.00
        Balance
        Gift Card Number:

        No gift card matches the entered value.

    • Continuing Education
    • More
      • Virtual Events
        • All Virtual Events
        • Upcoming
        • On-Demand
        • Posters
        • Companies
        • Health & Medicine
        • Clinical & Molecular DX
        • Immunology
        • Cardiology
        • Cancer
        • Cell & Molecular Biology
        • Genetics & Genomics
        • Microbiology
        • Neuroscience
        • Plants & Animals
        • Earth & The Environment
        • Chemistry & Physics
        • Technology
        • Cannabis Sciences
        • Drug Discovery & Development
        Webinars
        • All Webinars
        • Upcoming
        • On-Demand
        • Health & Medicine
        • Clinical & Molecular DX
        • Immunology
        • Cardiology
        • Cancer
        • Cell & Molecular Biology
        • Genetics & Genomics
        • Microbiology
        • Neuroscience
        • Plants & Animals
        • Earth & The Environment
        • Chemistry & Physics
        • Technology
        • Cannabis Sciences
        • Drug Discovery & Development
        Trending News
        • Most Recent
        • What's Hot
        • Health & Medicine
        • Clinical & Molecular DX
        • Immunology
        • Cardiology
        • Cancer
        • Cell & Molecular Biology
        • Genetics & Genomics
        • Microbiology
        • Neuroscience
        • Drug Discovery & Development
        • Plants & Animals
        • Cannabis Sciences
        • Earth & The Environment
        • Space & Astronomy
        • Chemistry & Physics
        • Technology
        Multimedia
        • Sponsored Content
        • eBooks
        • Podcasts
        • Infographics
        Companies
        Science Store
        • Men's T-Shirts
        • Women's T-Shirts
        • Accessories
        • Gift Cards
        • Gift Card Balance
        Continuing Education
        Company
        • About Us
        • The Team
        • Careers
        • Press Room
        • Social Media
        • Press Releases
        • Editorial & Writing Team
        • Blog
        • Scholarships
        • RSS
        • Contact Us
        • Continuing Education
        • Leaderboard
        Advertise
        • Media Kit
        • Custom Virtual Events
        • Virtual Event Series
        • Hybrid Events
        • Digital Advertising
        • Webinars
        • Rate Card
        • Editorial Calendar
        • Posters
        • Case Studies
        • Testimonials
        • Request Demo
        Forms
        • Audience Selection Form
        • Social Media Preference Forms
        • Custom Virtual Event Email Form
        • Sponsored Content Selection Form
        Legal
        • Terms and Conditions
        • Privacy Policy
        • Order Policy
        • Shipping Policy
        • Copyrights
        • User Agreement
        • User Data Request
        Support
        Company
        • About Us
        • The Team
        • Careers
        • Press Room
        • Social Media
        • Press Releases
        • Editorial & Writing Team
        • Media Partnerships
        • Blog
        • Scholarships
        • Continuing Education
        • Leaderboard
        • Contact Us
        Advertise
        • Media Kit
        • Custom Virtual Events
        • Virtual Event Series
        • Hybrid Events
        • Digital Advertising
        • Webinars
        • Rate Card
        • Editorial Calendar
        • Posters
        • Case Studies
        • Testimonials
        • Request Demo
        Forms
        • Audience Selection Form
        • Social Media Preference Forms
        • Custom Virtual Event Email Form
        • Sponsored Content Selection Form
        Legal
        • Terms and Conditions
        • Privacy Policy
        • Order Policy
        • Shipping Policy
        • Copyrights
        • User Agreement
        • User Data Request
        Request Demo
        Interested in Advertising
        with Labroots?
        Have questions? Visit our Support pages
    Login here
    Register Free
    Follow

    Cancer

    Cancer: is a disease in which abnormal cells divide uncontrollably and destroy body tissue. Cancerous tumors are malignant, which means they can spread into, or invade, nearby tissues.

    Webinars

    • OCT 16, 2013 | 2:00 PM
      C.E. CREDITS
      PSA Screening and Early Detection for Prostate Cancer 2013: Controversy and Opportunity
      PSA Screening and Early Detection for Prostate Cancer 2013: Controversy...
      While the Prostate Specific Antigen (PSA) blood test has been available since 1986 and FDA-approved for the early detection of prostate cancer since the early 1990s, 2012 marked a critical in...
      Speaker: Judd W Moul, MD, FACS
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      80
      OCT 16, 2013 | 1:00 PM
      C.E. CREDITS
      Investigating tissue specificity of cancer-causing germline mutations
      Investigating tissue specificity of cancer-causing germline mutations
      The remarkable diversity we see between different cell types in the human body is governed by the specificity attained through transcriptional and epigenetic regulatory programs. Cancer is a...
      Speaker: Jessica C. Mar, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      68
      OCT 16, 2013 | 1:00 PM
      C.E. CREDITS
      Resistance to AR Signaling Inhibitors in Castration Resistant Prostate Cancer
      Resistance to AR Signaling Inhibitors in Castration Resistant...
      While androgen deprivation therapy (ADT) remains the primary treatment modality for patients with metastatic prostate cancer (PCa), treatment is uniformly marked by progression to castration-...
      Speaker: Elahe A Mostaghel, MD, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      80
      OCT 16, 2013 | 1:00 PM
      C.E. CREDITS
      Molecular Diagnostics in Detection, Diagnosis, and Prognosis of Cancer
      Molecular Diagnostics in Detection, Diagnosis, and Prognosis of...
      Cancer cells have historically been classified by microscopic analysis of blood smears and tissue sections. Current technologies use molecular techniques to categorize and classify tumor cell...
      Speaker: Kristin Landis-Piwowar, PhD, MLS
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      129
      OCT 16, 2013 | 12:00 PM
      C.E. CREDITS
      New therapeutic strategies and new modes of drug resistance: From the bench to bedside and back again with the oncogene eIF4E
      New therapeutic strategies and new modes of drug resistance: From...
      The eukaryotic translation initiation factor eIF4E is a potent oncogene estimated to be elevated in about 30% of human cancers including cancers of the breast, prostate, lung, colon as well a...
      Speaker: Katherine LB Borden, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      60
      OCT 16, 2013 | 12:00 PM
      Fast-Tracking Molecular Diagnostics in Oncology via Antibody-Based Proteomics and Digital Pathology
      Fast-Tracking Molecular Diagnostics in Oncology via Antibody-Based...
      The effective implementation of personalised cancer therapeutic regimens depends on the successful identification and translation of informative biomarkers to aid clinical decision making. Th...
      Speaker: William M. Gallagher, PhD.
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      98
      OCT 16, 2013 | 11:00 AM
      C.E. CREDITS
      Embracing Complexity: Drosophila as a Tool to Develop Cancer Therapeutics
      Embracing Complexity: Drosophila as a Tool to Develop Cancer Therapeutics
      Cancer and diabetes are complex diseases that have proven difficult to treat in the clinics. Until recently, most efforts have focused on hitting individual therapeutic targets cleanly. Unfor...
      Speaker: Ross L. Cagan, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      78
      OCT 16, 2013 | 11:00 AM
      SuperSelective PCR Primers for the Detection of Rare Mutant Cancer Cells in Clinical Samples Containing Abundant Normal Cells
      SuperSelective PCR Primers for the Detection of Rare Mutant Cancer...
      "SuperSelective" primers, by virtue of their unique design, enable only a few molecules of a mutant sequence to generate amplicons in conventional, real-time PCR assays without interference...
      Speaker: Fred Kramer, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      90
      OCT 16, 2013 | 11:00 AM
      Molecular Prognosis in the Management of Early Stage Lung Cancer
      Molecular Prognosis in the Management of Early Stage Lung Cancer
      Survival rates for early stage non-small cell lung cancer (NSCLC) remain unacceptably low compared to other common solid tumors. This mortality reflects a weakness in conventional staging, a...
      Speaker: Michael J Mann, MD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      58
      OCT 16, 2013 | 10:00 AM
      C.E. CREDITS
      Keynote: Is Personalized (Molecularly-Based) Medicine our Best Hope to Finally Defeat Cancer?
      Keynote: Is Personalized (Molecularly-Based) Medicine our Best...
      The current paradigm of detecting established cancer (often too late) and treating routinely with cytotoxic drugs is beginning to change. Advanced technologies such as whole genome sequencin...
      Speaker: Anna Barker, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      37
      OCT 16, 2013 | 9:00 AM
      C.E. CREDITS
      Keynote: Breast Cancer Genomics and Genetics
      Keynote: Breast Cancer Genomics and Genetics
      It is now appreciated that breast cancer is not a single disease, but instead is a spectrum of tumor subtypes with distinct cellular origins, somatic changes and somewhat predictable clinical...
      Speaker: Charles M. Perou, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      132
      OCT 16, 2013 | 7:00 AM
      C.E. CREDITS
      Prognostic, predictive, and surrogate biomarkers in men with castration resistant metastatic prostate cancer
      Prognostic, predictive, and surrogate biomarkers in men with castration...
      With the rapid rise in the number of therapeutic options for men with castration-resistant prostate cancer (CRPC) comes increasingly complicated treatment decision-making, emphasizing the nee...
      Speaker: Andrew Armstrong, MD ScM FACP
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      96
      OCT 16, 2013 | 7:00 AM
      Metabolic reprogramming: links to the epigenome
      Metabolic reprogramming: links to the epigenome
      Cancer cells are characterized by major alterations in both cellular metabolism and epigenetic profiles. Current understanding of links between metabolism and chromatin in the context of can...
      Speaker: Kathryn E Wellen, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      108
      OCT 16, 2013 | 7:00 AM
      C.E. CREDITS
      Novel strategies for the targeted delivery of anti-cancer drugs in bladder cancer  CME and CE Credits Available
      Novel strategies for the targeted delivery of anti-cancer drugs...
      The adjuvant therapy of choice for superficial bladder cancer is the intravesical instillation of live Mycobacterium bovis Bacillus Calmette-Guerin (BCG). In spite of the fact that this thera...
      Speaker: R. Claudio Aguilar, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      34
      OCT 16, 2013 | 6:00 AM
      Building an Ion AmpliSeq Colon and Lung Cancer Panel - Consortium development of a tool for clinical research applications
      Building an Ion AmpliSeq Colon and Lung Cancer Panel - Consortium...
      The knowledge of molecular alterations involved in colon carcinoma (CRC) and non-small-cell lung carcinoma (NSCLC) has significantly increased in the past few years. Molecular subgroups of t...
      Speaker: Nicola Normanno, MD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      102
      AUG 22, 2013 | 5:00 PM
      C.E. CREDITS
      Genomic Profiles of Asian Endemic Cancers
      Genomic Profiles of Asian Endemic Cancers
      Malignancies caused by so-called Type I chemical and biological carcinogens provide important opportunities studying early events in cancer development, providing essential information for de...
      Speaker: Prof. Patrick Tan, MD, PhD
      Presented at: Genetics and Genomics Virtual Event Series 2013
      38
      AUG 22, 2013 | 5:00 PM
      Clinical Utility Potential of Epigenetic Aberrations in Human Solid Tumors
      Clinical Utility Potential of Epigenetic Aberrations in Human...
      As Chief of Scientific Intelligence at the John Wayne Cancer Institute, Dr. Hoon interacts with external academic, industry, and government agencies to develop innovative translational rese...
      Speaker: Dave S Hoon, PhD
      Presented at: Genetics and Genomics Virtual Event Series 2013
      104
      AUG 22, 2013 | 3:00 PM
      Next-generation Cancer Care in the Age of Genomics, Precision Medicine, High Throughput Biology
      Next-generation Cancer Care in the Age of Genomics, Precision...
      Developments in DNA sequencing technology have provided a unique opportunity for diagnosis and discovery of genetic alterations for rare diseases. Partnering with 20 academic centers in the U...
      Speaker: C Jimmy Lin, MD, PhD, MHS
      Presented at: Genetics and Genomics Virtual Event Series 2013
      114
      AUG 22, 2013 | 2:00 PM
      Translation and Clinical Application of Innovative Genomic Analysis: Challenges Remain
      Translation and Clinical Application of Innovative Genomic Analysis:...
      The role of the human genome in normal and patho-biology is crucial. Applied in cancer care and in a variety of unknown disorder settings, it can provide key insights and crucial diagnostic/p...
      Speaker: Paul Billings, MD, PhD
      Presented at: Genetics and Genomics Virtual Event Series 2013
      92
      AUG 22, 2013 | 2:00 PM
      The Road to Genomic Medicine is Paved with Data and Information
      The Road to Genomic Medicine is Paved with Data and Information
      Since the introduction of second-generation DNS sequencing technologies in 2007, the cost of genome sequencing has been consistently by 33% per quarter, with the $1000 genome arriving in 2012...
      Speaker: John Quackenbush, PhD
      Presented at: Genetics and Genomics Virtual Event Series 2013
      110
      AUG 22, 2013 | 1:00 PM
      Embracing the Complexity of Cancer: Seeing the Forest and the Trees
      Embracing the Complexity of Cancer: Seeing the Forest and the...
      Personalized medicine is transforming biomedical research and healthcare service delivery. Disease definition, diagnosis, treatment, and prevention are being fundamentally altered by the capa...
      Speaker: Kenneth Buetow, PhD, FACMI
      Presented at: Genetics and Genomics Virtual Event Series 2013
      92
      AUG 22, 2013 | 1:00 PM
      Dominant regulation of gene expression by microRNAs
      Dominant regulation of gene expression by microRNAs
      MicroRNAs are short non-coding cellular regulators of gene expression. Each microRNA controls the expression of a large set of genes, and microRNAs collectively, may regulate more than half o...
      Speaker: Noam Shomron, PhD
      Presented at: Genetics and Genomics Virtual Event Series 2013
      121
      AUG 22, 2013 | 10:00 AM
      C.E. CREDITS
      Using Prostate Cancer Exome Data to Identify Candidate Genes
      Using Prostate Cancer Exome Data to Identify Candidate Genes
      In this presentation, exome data from individuals with prostate cancer will be aligned against an annotated reference human genome and SNPs will be identified using DNASTARs SeqMan NGen softw...
      Speaker: Matthew Keyser, MS
      Presented at: Genetics and Genomics Virtual Event Series 2013
      60
      AUG 22, 2013 | 7:00 AM
      C.E. CREDITS
      Metabolic reprogramming: links to the epigenome
      Metabolic reprogramming: links to the epigenome
      Cancer cells are characterized by major alterations in both cellular metabolism and epigenetic profiles. Current understanding of links between metabolism and chromatin in the context of canc...
      Speaker: Kathryn E Wellen, PhD
      Presented at: Genetics and Genomics Virtual Event Series 2013
      96
    OCT 16, 2013 | 2:00 PM
    C.E. CREDITS
    PSA Screening and Early Detection for Prostate Cancer 2013: Controversy and Opportunity
    PSA Screening and Early Detection for Prostate Cancer 2013: Controversy...
    While the Prostate Specific Antigen (PSA) blood test has been available since 1986 and FDA-approved for the early detection of prostate cancer since the early 1990s, 2012 marked a critical in...
    Speaker: Judd W Moul, MD, FACS
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    80
    OCT 16, 2013 | 1:00 PM
    C.E. CREDITS
    Investigating tissue specificity of cancer-causing germline mutations
    Investigating tissue specificity of cancer-causing germline mutations
    The remarkable diversity we see between different cell types in the human body is governed by the specificity attained through transcriptional and epigenetic regulatory programs. Cancer is a...
    Speaker: Jessica C. Mar, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    68
    OCT 16, 2013 | 1:00 PM
    C.E. CREDITS
    Resistance to AR Signaling Inhibitors in Castration Resistant Prostate Cancer
    Resistance to AR Signaling Inhibitors in Castration Resistant...
    While androgen deprivation therapy (ADT) remains the primary treatment modality for patients with metastatic prostate cancer (PCa), treatment is uniformly marked by progression to castration-...
    Speaker: Elahe A Mostaghel, MD, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    80
    OCT 16, 2013 | 1:00 PM
    C.E. CREDITS
    Molecular Diagnostics in Detection, Diagnosis, and Prognosis of Cancer
    Molecular Diagnostics in Detection, Diagnosis, and Prognosis of...
    Cancer cells have historically been classified by microscopic analysis of blood smears and tissue sections. Current technologies use molecular techniques to categorize and classify tumor cell...
    Speaker: Kristin Landis-Piwowar, PhD, MLS
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    129
    OCT 16, 2013 | 12:00 PM
    C.E. CREDITS
    New therapeutic strategies and new modes of drug resistance: From the bench to bedside and back again with the oncogene eIF4E
    New therapeutic strategies and new modes of drug resistance: From...
    The eukaryotic translation initiation factor eIF4E is a potent oncogene estimated to be elevated in about 30% of human cancers including cancers of the breast, prostate, lung, colon as well a...
    Speaker: Katherine LB Borden, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    60
     
     
  • OCT 16, 2013 | 12:00 PM
    Fast-Tracking Molecular Diagnostics in Oncology via Antibody-Based Proteomics and Digital Pathology
    Fast-Tracking Molecular Diagnostics in Oncology via Antibody-Based...
    The effective implementation of personalised cancer therapeutic regimens depends on the successful identification and translation of informative biomarkers to aid clinical decision making. Th...
    Speaker: William M. Gallagher, PhD.
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    98
    OCT 16, 2013 | 11:00 AM
    C.E. CREDITS
    Embracing Complexity: Drosophila as a Tool to Develop Cancer Therapeutics
    Embracing Complexity: Drosophila as a Tool to Develop Cancer Therapeutics
    Cancer and diabetes are complex diseases that have proven difficult to treat in the clinics. Until recently, most efforts have focused on hitting individual therapeutic targets cleanly. Unfor...
    Speaker: Ross L. Cagan, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    78
    OCT 16, 2013 | 11:00 AM
    SuperSelective PCR Primers for the Detection of Rare Mutant Cancer Cells in Clinical Samples Containing Abundant Normal Cells
    SuperSelective PCR Primers for the Detection of Rare Mutant Cancer...
    "SuperSelective" primers, by virtue of their unique design, enable only a few molecules of a mutant sequence to generate amplicons in conventional, real-time PCR assays without interference...
    Speaker: Fred Kramer, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    90
    OCT 16, 2013 | 11:00 AM
    Molecular Prognosis in the Management of Early Stage Lung Cancer
    Molecular Prognosis in the Management of Early Stage Lung Cancer
    Survival rates for early stage non-small cell lung cancer (NSCLC) remain unacceptably low compared to other common solid tumors. This mortality reflects a weakness in conventional staging, a...
    Speaker: Michael J Mann, MD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    58
    OCT 16, 2013 | 10:00 AM
    C.E. CREDITS
    Keynote: Is Personalized (Molecularly-Based) Medicine our Best Hope to Finally Defeat Cancer?
    Keynote: Is Personalized (Molecularly-Based) Medicine our Best...
    The current paradigm of detecting established cancer (often too late) and treating routinely with cytotoxic drugs is beginning to change. Advanced technologies such as whole genome sequencin...
    Speaker: Anna Barker, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    37
     
     
  • OCT 16, 2013 | 9:00 AM
    C.E. CREDITS
    Keynote: Breast Cancer Genomics and Genetics
    Keynote: Breast Cancer Genomics and Genetics
    It is now appreciated that breast cancer is not a single disease, but instead is a spectrum of tumor subtypes with distinct cellular origins, somatic changes and somewhat predictable clinical...
    Speaker: Charles M. Perou, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    132
    OCT 16, 2013 | 7:00 AM
    C.E. CREDITS
    Prognostic, predictive, and surrogate biomarkers in men with castration resistant metastatic prostate cancer
    Prognostic, predictive, and surrogate biomarkers in men with castration...
    With the rapid rise in the number of therapeutic options for men with castration-resistant prostate cancer (CRPC) comes increasingly complicated treatment decision-making, emphasizing the nee...
    Speaker: Andrew Armstrong, MD ScM FACP
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    96
    OCT 16, 2013 | 7:00 AM
    Metabolic reprogramming: links to the epigenome
    Metabolic reprogramming: links to the epigenome
    Cancer cells are characterized by major alterations in both cellular metabolism and epigenetic profiles. Current understanding of links between metabolism and chromatin in the context of can...
    Speaker: Kathryn E Wellen, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    108
    OCT 16, 2013 | 7:00 AM
    C.E. CREDITS
    Novel strategies for the targeted delivery of anti-cancer drugs in bladder cancer  CME and CE Credits Available
    Novel strategies for the targeted delivery of anti-cancer drugs...
    The adjuvant therapy of choice for superficial bladder cancer is the intravesical instillation of live Mycobacterium bovis Bacillus Calmette-Guerin (BCG). In spite of the fact that this thera...
    Speaker: R. Claudio Aguilar, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    34
    OCT 16, 2013 | 6:00 AM
    Building an Ion AmpliSeq Colon and Lung Cancer Panel - Consortium development of a tool for clinical research applications
    Building an Ion AmpliSeq Colon and Lung Cancer Panel - Consortium...
    The knowledge of molecular alterations involved in colon carcinoma (CRC) and non-small-cell lung carcinoma (NSCLC) has significantly increased in the past few years. Molecular subgroups of t...
    Speaker: Nicola Normanno, MD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    102
     
     
  • AUG 22, 2013 | 5:00 PM
    C.E. CREDITS
    Genomic Profiles of Asian Endemic Cancers
    Genomic Profiles of Asian Endemic Cancers
    Malignancies caused by so-called Type I chemical and biological carcinogens provide important opportunities studying early events in cancer development, providing essential information for de...
    Speaker: Prof. Patrick Tan, MD, PhD
    Presented at: Genetics and Genomics Virtual Event Series 2013
    38
    AUG 22, 2013 | 5:00 PM
    Clinical Utility Potential of Epigenetic Aberrations in Human Solid Tumors
    Clinical Utility Potential of Epigenetic Aberrations in Human...
    As Chief of Scientific Intelligence at the John Wayne Cancer Institute, Dr. Hoon interacts with external academic, industry, and government agencies to develop innovative translational rese...
    Speaker: Dave S Hoon, PhD
    Presented at: Genetics and Genomics Virtual Event Series 2013
    104
    AUG 22, 2013 | 3:00 PM
    Next-generation Cancer Care in the Age of Genomics, Precision Medicine, High Throughput Biology
    Next-generation Cancer Care in the Age of Genomics, Precision...
    Developments in DNA sequencing technology have provided a unique opportunity for diagnosis and discovery of genetic alterations for rare diseases. Partnering with 20 academic centers in the U...
    Speaker: C Jimmy Lin, MD, PhD, MHS
    Presented at: Genetics and Genomics Virtual Event Series 2013
    114
    AUG 22, 2013 | 2:00 PM
    Translation and Clinical Application of Innovative Genomic Analysis: Challenges Remain
    Translation and Clinical Application of Innovative Genomic Analysis:...
    The role of the human genome in normal and patho-biology is crucial. Applied in cancer care and in a variety of unknown disorder settings, it can provide key insights and crucial diagnostic/p...
    Speaker: Paul Billings, MD, PhD
    Presented at: Genetics and Genomics Virtual Event Series 2013
    92
    AUG 22, 2013 | 2:00 PM
    The Road to Genomic Medicine is Paved with Data and Information
    The Road to Genomic Medicine is Paved with Data and Information
    Since the introduction of second-generation DNS sequencing technologies in 2007, the cost of genome sequencing has been consistently by 33% per quarter, with the $1000 genome arriving in 2012...
    Speaker: John Quackenbush, PhD
    Presented at: Genetics and Genomics Virtual Event Series 2013
    110
     
     
  • AUG 22, 2013 | 1:00 PM
    Embracing the Complexity of Cancer: Seeing the Forest and the Trees
    Embracing the Complexity of Cancer: Seeing the Forest and the...
    Personalized medicine is transforming biomedical research and healthcare service delivery. Disease definition, diagnosis, treatment, and prevention are being fundamentally altered by the capa...
    Speaker: Kenneth Buetow, PhD, FACMI
    Presented at: Genetics and Genomics Virtual Event Series 2013
    92
    AUG 22, 2013 | 1:00 PM
    Dominant regulation of gene expression by microRNAs
    Dominant regulation of gene expression by microRNAs
    MicroRNAs are short non-coding cellular regulators of gene expression. Each microRNA controls the expression of a large set of genes, and microRNAs collectively, may regulate more than half o...
    Speaker: Noam Shomron, PhD
    Presented at: Genetics and Genomics Virtual Event Series 2013
    121
    AUG 22, 2013 | 10:00 AM
    C.E. CREDITS
    Using Prostate Cancer Exome Data to Identify Candidate Genes
    Using Prostate Cancer Exome Data to Identify Candidate Genes
    In this presentation, exome data from individuals with prostate cancer will be aligned against an annotated reference human genome and SNPs will be identified using DNASTARs SeqMan NGen softw...
    Speaker: Matthew Keyser, MS
    Presented at: Genetics and Genomics Virtual Event Series 2013
    60
    AUG 22, 2013 | 7:00 AM
    C.E. CREDITS
    Metabolic reprogramming: links to the epigenome
    Metabolic reprogramming: links to the epigenome
    Cancer cells are characterized by major alterations in both cellular metabolism and epigenetic profiles. Current understanding of links between metabolism and chromatin in the context of canc...
    Speaker: Kathryn E Wellen, PhD
    Presented at: Genetics and Genomics Virtual Event Series 2013
    96
    Related Tags
    See more See less
    Let's Talk Science. Let's Talk Medicine.

    The leading scientific social networking website and producer of educational virtual events and webinars.

    About Us The Team Contact Us Careers Media Kit Virtual Events Posters Multimedia Blog Press Room Science Store Gift Card Balance
    Continuing Education Scholarships Leaderboard Order Policy Shipping Policy Privacy Policy Terms and Conditions User Agreement User Data Request Copyrights Support Chati
    © 2008-2025 Labroots Inc.
    Opens in a new window Opens an external site Opens an external site in a new window
    Modal title